Literature DB >> 6435250

Chemotherapy of ovarian cancer.

R F Ozols, R C Young.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435250

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  43 in total

1.  Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.

Authors:  L Camera; S Del Vecchio; A Petrillo; G Esposito; G Frasci; R V Iaffaioli; A R Bianco; M Salvatore
Journal:  Eur J Nucl Med       Date:  1991

2.  In vitro pharmacological study of monomeric platinum(III) hematoporphyrin IX complexes.

Authors:  Georgi Momekov; Margarita Karaivanova; Iva Ugrinova; Evdokia Pasheva; Galina Gencheva; Daniela Tsekova; Sonia Arpadjan; Panayot R Bontchev
Journal:  Invest New Drugs       Date:  2010-03-13       Impact factor: 3.850

3.  Discrepancy between cytotoxicity and DNA interstrand crosslinking of carboplatin and cisplatin in vivo.

Authors:  W DeNeve; F Valeriote; E Tapazoglou; C Everett; A Khatana; T Corbett
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

4.  Activity of 2-fluoro-Ara AMP against gynecologic tumors in the soft agar assay.

Authors:  J A Ajani; B Tomasovic; G Spitzer; J J Kavanagh; D Thielvoldt; F L Baker; D Gershenson
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

5.  Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.

Authors:  K J Scanlon; M Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

6.  Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel.

Authors:  Mohamed Kamel Hassan; Hidemichi Watari; Lane Christenson; Saverio Bettuzzi; Noriaki Sakuragi
Journal:  Tumour Biol       Date:  2011-07-15

Review 7.  MicroRNAs in ovarian carcinomas.

Authors:  Neetu Dahiya; Patrice J Morin
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

8.  β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells.

Authors:  Rebecca X Lee; Qingdi Quentin Li; Eddie Reed
Journal:  Anticancer Res       Date:  2012-08       Impact factor: 2.480

9.  The role of chemotherapy including ifosfamide for ovarian carcinoma. Austrian Collab. Ovarian Cancer Study Group.

Authors:  K Karrer; H Salzer; P Sevelda; C Dittrich
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 10.  The current and future place of vinorelbine in cancer therapy.

Authors:  E Cvitkovic; J Izzo
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.